drugset

drugset / Trial / NCT01802723

Dose Ranging Study

NCT01802723 ↗

Phase 2 Completed 472 enrolled Neothetics, Inc

RandomizedParallel-groupQuadruple-blindTreatment

Summary

Dose Ranging Study

Timeline

Start: 2013-02
Primary completion: 2013-06
Completion: 2013-10

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Salmeterol	Other / unclassified	—	—

Indications